Improving lung cancer treatment through biomarker development and collaboration.
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
This study is looking for new ways to make lung cancer treatments work better by finding special markers in the body, and it’s inviting patients to join clinical trials that explore these exciting new options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11251412 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment of lung cancer by developing novel biomarkers that can improve the effectiveness of immunotherapy and targeted therapies. The team at Emory University collaborates with various institutions to share specimens and conduct pilot projects that are directly relevant to clinical trials. By utilizing genomic, epigenomic, and proteomic approaches, the research aims to identify new treatment strategies and overcome resistance to existing therapies. Patients may have the opportunity to participate in clinical trials that utilize these innovative approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with lung cancer who may benefit from advanced biomarker-driven therapies.
Not a fit: Patients with lung cancer who are not eligible for clinical trials or those with very late-stage disease may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for lung cancer patients.
How similar studies have performed: Previous research has shown success in using biomarker-driven approaches to improve lung cancer treatment outcomes, indicating that this approach is promising.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Leal, Ticiana — Emory University
- Study coordinator: Leal, Ticiana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.